Movano Inc. (NASDAQ:MOVE – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $11.09 and traded as high as $16.48. Movano shares last traded at $14.71, with a volume of 50,966 shares traded.
Movano News Summary
Here are the key news stories impacting Movano this week:
- Positive Sentiment: Technical support in place — MOVE is trading above its 50?day ($13.98) and 200?day ($11.09) moving averages, which can act as short?term support and may limit immediate downside for a bounce.
- Neutral Sentiment: Low liquidity and small market cap amplify moves — trading volume today (?50,954) is far below the stock’s average (~1.03M) and the market cap is tiny (~$16.6M). Price changes can be driven by relatively small orders, so single?day moves may not reflect broad investor conviction.
- Negative Sentiment: Company fundamentals remain the primary negative catalyst — Movano’s March quarter results showed a large EPS miss and almost no reported revenue (company reported ($5.88) EPS vs. consensus ~($3.60), revenue ~$0.04M vs. ~$7.63M expected), along with deeply negative margins and ROE. Those weak operating and revenue figures are the clearest reason for ongoing selling pressure. Read More.
- Negative Sentiment: Broader risk?off tone in markets is weighing on riskier / small?cap tech names — recent signs of weakening risk appetite (crypto ETF outflows and a sharp drop in the Fear & Greed Index) plus central?bank uncertainty are nudging investors toward safety, which can pressure illiquid microcaps like MOVE. Read More. and Read More.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on MOVE. Wall Street Zen raised Movano from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. Weiss Ratings reissued a “sell (e+)” rating on shares of Movano in a research report on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Movano has an average rating of “Sell”.
Movano Price Performance
The company has a market capitalization of $16.62 million, a price-to-earnings ratio of -1.39 and a beta of 0.80. The business’s 50-day moving average price is $13.98 and its two-hundred day moving average price is $11.11.
Movano (NASDAQ:MOVE – Get Free Report) last issued its quarterly earnings results on Monday, March 30th. The technology company reported ($5.88) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($3.60) by ($2.28). The company had revenue of $0.04 million for the quarter, compared to analyst estimates of $7.63 million. Movano had a negative return on equity of 647.91% and a negative net margin of 4,231.41%.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC acquired a new stake in Movano Inc. (NASDAQ:MOVE – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned about 5.94% of Movano at the end of the most recent reporting period. 16.64% of the stock is owned by institutional investors.
Movano Company Profile
Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.
Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.
Recommended Stories
Receive News & Ratings for Movano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Movano and related companies with MarketBeat.com's FREE daily email newsletter.
